Literature DB >> 22314254

Prion-induced toxicity in PrP transgenic Drosophila.

Alana M Thackray1, Farooq Muhammad, Chang Zhang, Margaret Denyer, John Spiropoulos, Damian C Crowther, Raymond Bujdoso.   

Abstract

Prion diseases are fatal transmissible neurodegenerative diseases of humans and various vertebrate species. In their natural hosts these conditions are characterised by prolonged incubation times prior to the onset of clinical signs of terminal disease. Accordingly, tractable models of mammalian prion disease are required in order to better understand the mechanisms of prion replication and prion-induced neurotoxicity. Transmission of prion diseases can occur across a species barrier and this is facilitated in recipients transgenic for the same PrP gene as the individual from which the infectious prions are derived. Here we have tested the hypothesis that exogenous ovine prions can induce neurotoxicity in Drosophila melanogaster transgenic for ovine PrP. Drosophila that expressed ovine PrP pan neuronally and inoculated with ovine prions at the larval stage by oral exposure to scrapie-infected sheep brain homogenate showed markedly accelerated locomotor and survival defects. ARQ PrP transgenic Drosophila exposed to scrapie-infected brain homogenate showed a significant and progressive reduction in locomotor activity compared to similar flies exposed to normal sheep brain homogenate. The prion-induced locomotor defect was accompanied by the accumulation of potentially misfolded PrP in the brains of prion-inoculated flies. VRQ PrP transgenic Drosophila, which expressed less ovine PrP than ARQ flies, showed a reduced median survival compared to similar flies exposed to normal sheep brain homogenate. These prion-induced phenotypic effects were PrP-mediated since ovine prions were not toxic in non-PrP transgenic control flies. Our observations provide the basis of an invertebrate model of transmissible mammalian prion disease.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22314254     DOI: 10.1016/j.yexmp.2012.01.005

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  11 in total

Review 1.  Drosophila models of prionopathies: insight into prion protein function, transmission, and neurotoxicity.

Authors:  Pedro Fernandez-Funez; Jonatan Sanchez-Garcia; Diego E Rincon-Limas
Journal:  Curr Opin Genet Dev       Date:  2017-04-14       Impact factor: 5.578

Review 2.  Drosophila as an In Vivo Model for Human Neurodegenerative Disease.

Authors:  Leeanne McGurk; Amit Berson; Nancy M Bonini
Journal:  Genetics       Date:  2015-10       Impact factor: 4.562

3.  Prion protein stabilizes amyloid-β (Aβ) oligomers and enhances Aβ neurotoxicity in a Drosophila model of Alzheimer's disease.

Authors:  Nadine D Younan; Ko-Fan Chen; Ruth-Sarah Rose; Damian C Crowther; John H Viles
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

Review 4.  Prion-induced neurotoxicity: Possible role for cell cycle activity and DNA damage response.

Authors:  Raymond Bujdoso; Matthias Landgraf; Walker S Jackson; Alana M Thackray
Journal:  World J Virol       Date:  2015-08-12

5.  New Drosophila models to uncover the intrinsic and extrinsic factors that mediate the toxicity of the human prion protein.

Authors:  Ryan R Myers; Jonatan Sanchez-Garcia; Daniel C Leving; Richard G Melvin; Pedro Fernandez-Funez
Journal:  Dis Model Mech       Date:  2022-05-03       Impact factor: 5.732

6.  Genetic human prion disease modelled in PrP transgenic Drosophila.

Authors:  Alana M Thackray; Alzbeta Cardova; Hanna Wolf; Lydia Pradl; Ina Vorberg; Walker S Jackson; Raymond Bujdoso
Journal:  Biochem J       Date:  2017-09-20       Impact factor: 3.857

Review 7.  Prion disease: experimental models and reality.

Authors:  Sebastian Brandner; Zane Jaunmuktane
Journal:  Acta Neuropathol       Date:  2017-01-13       Impact factor: 17.088

8.  The use of PrP transgenic Drosophila to replace and reduce vertebrate hosts in the bioassay of mammalian prion infectivity.

Authors:  Alana M Thackray; Olivier Andréoletti; Raymond Bujdoso
Journal:  F1000Res       Date:  2018-05-15

9.  Mammalian prion propagation in PrP transgenic Drosophila.

Authors:  Alana M Thackray; Olivier Andréoletti; Raymond Bujdoso
Journal:  Brain       Date:  2018-09-01       Impact factor: 13.501

10.  Cytosolic PrP can participate in prion-mediated toxicity.

Authors:  Alana M Thackray; Chang Zhang; Tina Arndt; Raymond Bujdoso
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.